Sign In
Buy KRYS
$301.82
+8.61 (+2.94%)
At Close: Jun 03, 2026
Colin Farrell hails charity challenge by brave friend with rare...
10:50am, Thursday, 04'th Jun 2020
Emma Fogarty, who has a disorder known as butterfly skin, is trying to complete 36km to mark her 36th birthday later this month.
Colin Farrell hails charity challenge by brave friend with rare skin disease
10:49am, Thursday, 04'th Jun 2020
Emma Fogarty, who has a disorder known as butterfly skin, is trying to complete 36km to mark her 36th birthday later this month.
7 “Perfect 10” Stocks to Buy Now
02:00pm, Monday, 25'th May 2020
In a financial environment riddled with unprecedented levels of uncertainty, investors are at wits’ end. When it comes to finding an investment strategy that will yield returns, traditional methods
8 Biotechs Tapping Secondary Markets for $3 Billion
10:53pm, Tuesday, 19'th May 2020
Company stocks drop on dilution, but monies could benefit shareholders down the line Continue reading...
Krystal Biotech Announces Pricing of $125 Million Public Offering of Common Stock
01:57am, Tuesday, 19'th May 2020
Krystal Biotech, Inc. (KRYS) (the “Company”), a gene therapy company developing a new class of transformative medicines to treat diseases caused by gene or protein dysfunction, today announced tha
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs May 18)
ADC Therapeutics SA (NYSE:...
Krystal Biotech Announces Proposed Public Offering of Common Stock
08:15pm, Monday, 18'th May 2020
Krystal Biotech, Inc. (KRYS) (the “Company”), a gene therapy company developing a new class of transformative medicines to treat diseases caused by gene or protein dysfunction, today announced tha
Krystal Biotech, Inc. (KRYS), a gene therapy company dedicated to developing transformative medicines to treat diseases caused by protein or gene dysfunction, today announced interim results for a fir
The Week Ahead In Biotech: Virtual Conference Presentations, Clovis PDUFA Date In The Spotlight
12:00am, Sunday, 10'th May 2020
The smid-cap biotech earnings deluge hit Wall Street in the week ended May 9, positively impacting the stocks in the sector. The iShares NASDAQ Biotechnology Index (NASDAQ: IBB)...
Krystal Biotech Reports First Quarter 2020 Financial Results and Provides Update on Operational Progress
12:00pm, Monday, 04'th May 2020
KB105 interim Phase 1/2 clinical data for treatment of autosomal recessive congenital ichthyosis (ARCI) to be announced at the Society for Investigative Dermatology (SID) Annual.
Analysts Offer Insights on Healthcare Companies: Vaxart (VXRT), Karyopharm Therapeutics (KPTI) and Krystal Biotech (KRYS)
11:15am, Thursday, 30'th Apr 2020
There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Vaxart (VXRT), Karyopharm Therapeutics (KPTI) and Krystal
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Vaxart (
VXRT
–
Research Report
), Karyopharm Therapeutics (
KPTI
–
Research Report
) and Krystal B
Frazier Healthcare Partners Adds Experienced Capital Markets Executive to Life Sciences Team
12:00pm, Tuesday, 28'th Apr 2020
Frazier Healthcare Partners announced David Topper has joined the Life Sciences team as a Senior Advisor. He has over 35 years of experience in the capital markets.
Outlook Therapeutics Bolsters Clinical and Commercial Expertise with Two Key Appointments to Board of Directors
12:05pm, Tuesday, 21'st Apr 2020
Outlook Therapeutics, Inc. (OTLK) (the “Company”), a late clinical-stage biopharmaceutical company working to develop the first FDA-approved ophthalmic formulation of bevacizumab for use in
Outlook Therapeutics Bolsters Clinical and Commercial Expertise with Two Key Appointments to Board of Directors
12:05pm, Tuesday, 21'st Apr 2020
Internationally renowned ophthalmologist, Gerd Auffarth, MD, ranked as one of the “100 most influential personalities in ophthalmology worldwide" in the...
